T-cell immunity to influenza in older adults: A pathophysiological framework for development of more effective vaccines

Frontiers in Immunology

Volumn 7, Issue FEB, 2016, Pages

  McElhaney, Janet E ^a,b   Kuchel, George A ^b   Zhou, Xin ^b   Swain, Susan L ^c   Haynes, Laura ^b  

^a HEALTH SCIENCES NORTH   (Canada)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antibody; Cell mediated immunity; Immunosenescence; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 10;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONCEPTUAL FRAMEWORK; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE FUNCTION TEST; INFLAMMATION; INFLUENZA; MORTALITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; SENESCENCE; VACCINATION;

EID: 84961653804     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00041     Document Type: Article

References (106)

1. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet (2011) 377(9773):1264-75. doi:10.1016/S0140-6736(10)61459-6.
2. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol (2004) 160(5):492-502. doi:10.1093/aje/kwh227.
3. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 283(4):499-505. doi:10.1001/jama.283.4.499.
4. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA (2004) 292(11):1333-40. doi:10.1001/jama.292.11.1333.
5. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 289(2):179-86. doi:10.1001/jama.289.2.179.
6. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet (2012) 380(9836):37-43. doi:10.1016/S0140-6736(12)60240-2.
7. Hak E, Wei F, Nordin J, Mullooly J, Poblete S, Nichol KL. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis (2004) 189(3):450-8. doi:10.1086/381165.
8. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med (1998) 158(6):645-50. doi:10.1001/archinte.158.6.645.
9. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med (2005) 352(17):1749-59. doi:10.1056/NEJMoa043951.
10. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA (1997) 277(9):728-34.
11. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA (1994) 272(21):1661-5.
12. Groenwold RH, Nelson DB, Nichol KL, Hoes AW, Hak E. Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research. Int J Epidemiol (2010) 39(1):107-17. doi:10.1093/ije/dyp332.
13. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol (1988) 127(2):353-64.
14. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet (1995) 346(8975):591-5. doi:10.1016/S0140-6736(95)91434-X.
15. Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA (2004) 292(17):2089-95. doi:10.1001/jama.292.17.2089.
16. MacDonald E, McNeil S, McGreer A, McElhaney J, Johnstone J, MacKinnon-Cameron D, et al. Frailty in relation to influenza burden of disease and serious outcomes: a report from the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) Network. Canadian Immunization Conference; December 2-4, 2014. Ottawa: (2014).
17. Rockwood K, Song X, Mitnitski A. Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey. CMAJ (2011) 183(8):E487-94. doi:10.1503/cmaj.101271.
18. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet (2013) 381(9868):752-62. doi:10.1016/S0140-6736(12)62167-9.
19. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 7(10):658-66. doi:10.1016/S1473-3099(07)70236-0.
20. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 372(9636):398-405. doi:10.1016/S0140-6736(08)61160-5.
21. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev (2010) 17(2):CD004876. doi:10.1002/14651858.CD004876.pub3.
22. Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 31(50):6030-3. doi:10.1016/j.vaccine.2013.09.063.
23. Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Reply: letter to the editor, cochrane rearranged. Vaccine (2015) 33(1):13-4. doi:10.1016/j.vaccine.2014.05.045.
24. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev (2005) 126(2):351-61.
25. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2007) 128(1):92-105. doi:10.1016/j.mad.2006.11.016.
26. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol (2004) 59(3):255-63. doi:10.1093/gerona/59.3.M255.
27. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol (2007) 62(7):731-7. doi:10.1093/gerona/62.7.731.
28. Strandberg TE, Pitkala KH. Frailty in elderly people. Lancet (2007) 369(9570):1328-9. doi:10.1016/S0140-6736(07)60613-8.
29. Howlett SE, Rockwood MR, Mitnitski A, Rockwood K. Standard laboratory tests to identify older adults at increased risk of death. BMC Med (2014) 12:171. doi:10.1186/s12916-014-0171-9.
30. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc (2007) 55(5):780-91. doi:10.1111/j.1532-5415.2007.01156.x.
31. Stretton CM, Latham NK, Carter KN, Lee AC, Anderson CS. Determinants of physical health in frail older people: the importance of self-efficacy. Clin Rehabil (2006) 20(4):357-66. doi:10.1191/0269215506cr946oa.
32. Rockwood K, Rockwood MR, Mitnitski A. Physiological redundancy in older adults in relation to the change with age in the slope of a frailty index. J Am Geriatr Soc (2010) 58(2):318-23. doi:10.1111/j.1532-5415.2009.02667.x.
33. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc (2010) 58(4):681-7. doi:10.1111/j.1532-5415.2010.02764.x.
34. McNeil S, Johnstone J, Rockwood M, MacKinnon-Cameron D, Wang H, Ye L, et al. Impact of Hospitalization Due to Influenza on Frailty in Older Adults: Toward a Better Understanding of Burden of Disease. San Diego, CA: Infectious Diseases Society of America (2012).
35. Moro-Garcia MA, Alonso-Arias R, Lopez-Vazquez A, Suarez-Garcia FM, Solano-Jaurrieta JJ, Baltar J, et al. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr) (2012) 34(2):479-95. doi:10.1007/s11357-011-9240-6.
36. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr Opin Immunol (2009) 21(4):440-5. doi:10.1016/j.coi.2009.05.012.
37. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 75(24):12182-7. doi:10.1128/JVI.75.24.12182-12187.2001.
38. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol (2002) 168(11):5893-9. doi:10.4049/jimmunol.168.11.5893.
39. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol (2005) 79(6):3675-83. doi:10.1128/JVI.79.6.3675-3683.2005.
40. Pawelec G, Akbar A, Caruso C, Effros R, Grubeck-Loebenstein B, Wikby A. Is immunosenescence infectious? Trends Immunol (2004) 25(8):406-10. doi:10.1016/j.it.2004.05.006.
41. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis (2006) 43(9):1143-51. doi:10.1086/508173.
42. Schmaltz HN, Fried LP, Xue QL, Walston J, Leng SX, Semba RD. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc (2005) 53(5):747-54. doi:10.1111/j.1532-5415.2005.53250.x.
43. Choi YS, Eto D, Yang JA, Lao C, Crotty S. Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol (2013) 190(7):3049-53. doi:10.4049/jimmunol.1203032.
44. Jones SC, Brahmakshatriya V, Huston G, Dibble J, Swain SL. TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism. J Immunol (2010) 185(11):6783-94. doi:10.4049/jimmunol.0901296.
45. Zhang W, Brahmakshatriya V, Swain SL. CD4 T cell defects in the aged: causes, consequences and strategies to circumvent. Exp Gerontol (2014) 54:67-70. doi:10.1016/j.exger.2014.01.002.
46. Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis (2015) 211(7):1174-84. doi:10.1093/infdis/jiu573.
47. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis (2011) 203:158-67. doi:10.1093/infdis/jiq039.
48. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol (2006) 176(10):6333-9. doi:10.4049/jimmunol.176.10.6333.
49. McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis (2013) 13(6):485-96. doi:10.1016/S1473-3099(13)70046-X.
50. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med (2014) 371(7):635-45. doi:10.1056/NEJMoa1315727.
51. Haq K, McElhaney JE. Ageing and respiratory infections: the airway of ageing. Immunol Lett (2014) 162(1 Pt B):323-8. doi:10.1016/j.imlet.2014.06.009.
52. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol (2014) 29:38-42. doi:10.1016/j.coi.2014.03.008.
53. Frasca D, Blomberg BB. B cell function and influenza vaccine responses in healthy aging and disease. Curr Opin Immunol (2014) 29:112-8. doi:10.1016/j.coi.2014.05.008.
54. Baumgarth N, Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol (1996) 70(7):4411-8.
55. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest (2012) 122(8):2847-56. doi:10.1172/JCI63689.
56. Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med (1994) 180(4):1273-82. doi:10.1084/jem.180.4.1273.
57. Behzad H, Huckriede A, Haynes L, Gentleman B, Coyle K, Wilschut JC, et al. GLA-SE, a synthetic TLR4 agonist, enhances T cell responses to influenza vaccine in older adults. J Infect Dis (2012) 205(3):466-73. doi:10.1093/infdis/jir769.
58. Gorosito Serran M, Fiocca Vernengo F, Beccaria CG, Acosta Rodriguez EV, Montes CL, Gruppi A. The regulatory role of B cells in autoimmunity, infections and cancer: perspectives beyond IL10 production. FEBS Lett (2015) 589(22):3362-9. doi:10.1016/j.febslet.2015.08.048.
59. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, et al. The immune system in extreme longevity. Exp Gerontol (2008) 43(2):61-5. doi:10.1016/j.exger.2007.06.008.
60. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A (2003) 100(25):15053-8. doi:10.1073/pnas.2433717100.
61. Yager EJ, Kim IJ, Freeman ML, Lanzer KG, Burkum CE, Cookenham T, et al. Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus. Immun Ageing (2010) 7:3. doi:10.1186/1742-4933-7-3.
62. Dolfi DV, Mansfield KD, Kurupati RK, Kannan S, Doyle SA, Ertl HC, et al. Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans. PLoS One (2013) 8(10):e77164. doi:10.1371/journal.pone.0077164.
63. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med (2012) 18(2):274-80. doi:10.1038/nm.2612.
64. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 19(10):1305-12. doi:10.1038/nm.3350.
65. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine (1998) 16(18):1722-31. doi:10.1016/S0264-410X(98)00140-6.
66. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis (1993) 167(3):584-92. doi:10.1093/infdis/167.3.584.
67. McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, Hager WD, et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine (2009) 27:2418-25. doi:10.1016/j.vaccine.2009.01.136.
68. Shahid Z, Kleppinger A, Gentleman B, Falsey AR, McElhaney JE. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine (2010) 28(38):6145-51. doi:10.1016/j.vaccine.2010.07.036.
69. Talbot HK, Nian H, Zhu Y, Chen Q, Williams JV, Griffin MR. Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults. Clin Infect Dis (2015) 60(8):1170-5. doi:10.1093/cid/civ019.
70. Boxer R, Kleppinger A, Ahmad A, Annis K, Hager D, Kenny A. The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail (2010) 16(5):208-13. doi:10.1111/j.1751-7133.2010.00151.x.
71. Li H, Manwani B, Leng SX. Frailty, inflammation, and immunity. Aging Dis (2011) 2(6):466-73.
72. McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine (2012) 30(12):2060-7. doi:10.1016/j.vaccine.2012.01.015.
73. Derhovanessian E, Maier AB, Hahnel K, McElhaney JE, Slagboom EP, Pawelec G. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol (2014) 193(7):3624-31. doi:10.4049/jimmunol.1303361.
74. McElhaney JE, Garneau H, Camous X, Dupuis G, Pawelec G, Baehl S, et al. Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care (2015) 3(1):e000140. doi:10.1136/bmjdrc-2015-000140.
75. Najarro K, Nguyen H, Chen G, Xu M, Alcorta S, Yao X, et al. Telomere length as an indicator of the robustness of B-and T-cell response to influenza in older adults. J Infect Dis (2015) 212(8):1261-9. doi:10.1093/infdis/jiv202.
76. Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine (2011) 29(11):2169-77. doi:10.1016/j.vaccine.2010.12.029.
77. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol (2004) 173(1):673-81. doi:10.4049/jimmunol.173.1.673.
78. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol (2011) 29:621-63. doi:10.1146/annurev-immunol-031210-101400.
79. Maue AC, Eaton SM, Lanthier PA, Sweet KB, Blumerman SL, Haynes L. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol (2009) 182(10):6129-35. doi:10.4049/jimmunol.0804226.
80. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity (2011) 34(1):108-21. doi:10.1016/j.immuni.2010.12.012.
81. Rasheed AU, Rahn HP, Sallusto F, Lipp M, Muller G. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol (2006) 36(7):1892-903. doi:10.1002/eji.200636136.
82. Bentebibel SE, Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med (2013) 5(176):176ra32. doi:10.1126/scitranslmed.3005191.
83. Chevalier N, Jarrossay D, Ho E, Avery DT, Ma CS, Yu D, et al. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol (2011) 186(10):5556-68. doi:10.4049/jimmunol.1002828.
84. Herati RS, Reuter MA, Dolfi DV, Mansfield KD, Aung H, Badwan OZ, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol (2014) 193(7):3528-37. doi:10.4049/jimmunol.1302503.
85. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol (2009) 9(2):83-9. doi:10.1038/nri2474.
86. Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol (2006) 177(12):8348-55. doi:10.4049/jimmunol.177.12.8348.
87. Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 200(2):201-10. doi:10.1084/jem.20040298.
88. Garg SK, Delaney C, Toubai T, Ghosh A, Reddy P, Banerjee R, et al. Aging is associated with increased regulatory T-cell function. Aging Cell (2014) 13(3):441-8. doi:10.1111/acel.12191.
89. Mast BT, Azar AR, Murrell SA. The vascular depression hypothesis: the influence of age on the relationship between cerebrovascular risk factors and depressive symptoms in community dwelling elders. Aging Ment Health (2005) 9(2):146-52. doi:10.1080/13607860412331336832.
90. Micheel CM, Ball JR. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Institute of Medicine Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC (2010). doi:10.17226/12869.
91. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol (1997) 52(4):M201-8. doi:10.1093/gerona/52A.4.M201.
92. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta (2011) 1813(5):878-88. doi:10.1016/j.bbamcr.2011.01.034.
93. Bakker AD, Jaspers RT. IL-6 and IGF-1 signaling within and between muscle and bone: how important is the mTOR pathway for bone metabolism? Curr Osteoporos Rep (2015) 13(3):131-9. doi:10.1007/s11914-015-0264-1.
94. Pedersen BK, Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol (1985) (2009) 107(4):1006-14. doi:10.1152/japplphysiol.00734.2009.
95. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol (1985) (2005) 98(3):911-7. doi:10.1152/japplphysiol.01026.2004.
96. Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G. IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS One (2011) 6(3):e17392. doi:10.1371/journal.pone.0017392.
97. Washington TA, White JP, Davis JM, Wilson LB, Lowe LL, Sato S, et al. Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol (Oxf) (2011) 202(4):657-69. doi:10.1111/j.1748-1716.2011.02281.x.
98. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab (2008) 7(1):33-44. doi:10.1016/j.cmet.2007.11.011.
99. Voorhees PM, Manges RF, Sonneveld P, Jagannath S, Somlo G, Krishnan A, et al. A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. Br J Haematol (2013) 161(3):357-66. doi:10.1111/bjh.12266.
100. Nicklas BJ, Hsu FC, Brinkley TJ, Church T, Goodpaster BH, Kritchevsky SB, et al. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriatr Soc (2008) 56(11):2045-52. doi:10.1111/j.1532-5415.2008.01994.x.
101. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med (2014) 6(268):268ra179. doi:10.1126/scitranslmed.3009892.
102. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell (2014) 159(4):709-13. doi:10.1016/j.cell.2014.10.039.
103. Burch JB, Augustine AD, Frieden LA, Hadley E, Howcroft TK, Johnson R, et al. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol (2014) 69(Suppl 1):S1-3. doi:10.1093/gerona/glu041.
104. Effros RB. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine (2007) 25(4):599-604. doi:10.1016/j.vaccine.2006.08.032.
105. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis (2010) 50(5):747-51. doi:10.1086/650486.
106. Falsey AR, Baran A, Walsh EE. Should clinical case definitions of influenza in hospitalized older adults include fever? Influenza Other Respir Viruses (2015) 9(Suppl 1):23-9. doi:10.1111/irv.12316.